Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status

BACKGROUND: The benefit of palliative chemotherapy (PC) in patients with advanced solid tumors and poor performance status (ECOG-PS) has not been prospectively validated, which makes treatment decision challenging. We aimed to evaluate the overall survival, factors associated with early mortality, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorin de Vasconcellos, Vitor, RCC Bonadio, Renata, Avanço, Guilherme, Vailati Negrão, Marcelo, Pimenta Riechelmann, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528308/
https://www.ncbi.nlm.nih.gov/pubmed/31109330
http://dx.doi.org/10.1186/s12904-019-0427-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528308/
https://www.ncbi.nlm.nih.gov/pubmed/31109330
http://dx.doi.org/10.1186/s12904-019-0427-4

Ejemplares similares